(NaturalNews) Eli Lilly’s multibillion-dollar acquisition of a company developing experimental psychedelic therapies marks the largest investment yet by a drugmaker…
Pharma Eyes Psychedelics Market as Patients Seek New Depression Treatments
Estimated read time
1 min read
You May Also Like
More From Author
Patients lose when politicians play pharmacist
November 10, 2026
The big-city bill collectors are knocking at the statehouse door
November 10, 2026
